ChIP-seq in Studying Epigenetic Mechanisms of Disease and Promoting Precision Medicine: Progresses and Future Directions

References

• Ren B , RobertF , WyrickJJet al. Genome-wide location and function of DNA binding proteins . Science290 ( 5500 ), 2306 – 2309 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Landt SG , MarinovGK , KundajeAet al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia . Genome Res.22 ( 9 ), 1813 – 1831 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bailey T , KrajewskiP , LadungaIet al. Practical guidelines for the comprehensive analysis of ChIP-seq data . PLoS Comput. Biol.9 ( 11 ), e1003326 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bernstein BE , BirneyE , DunhamI , GreenED , GunterC , SnyderM . An integrated encyclopedia of DNA elements in the human genome . Nature489 ( 7414 ), 57 – 74 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kundaje A , MeulemanW , ErnstJet al. Integrative analysis of 111 reference human epigenomes . Nature518 ( 7539 ), 317 – 330 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Furey TS , SethupathyP . Genetics. Genetics driving epigenetics . Science342 ( 6159 ), 705 – 706 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Easwaran H , TsaiHC , BaylinSB . Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance . Mol. Cell54 ( 5 ), 716 – 727 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Pirola L , BalcerczykA , TothillRWet al. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells . Genome Res.21 ( 10 ), 1601 – 1615 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhang Z , ShiL , DawanyN , KelsenJ , PetriMA , SullivanKE . H3K4 tri-methylation breadth at transcription start sites impacts the transcriptome of systemic lupus erythematosus . Clin. Epigenetics8 , 14 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Peeters JG , VervoortSJ , TanSCet al. Inhibition of super-enhancer activity in autoinflammatory site-derived T cells reduces disease-associated gene expression . Cell Rep.12 ( 12 ), 1986 – 1996 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sazonova O , ZhaoY , NurnbergSet al. Characterization of TCF21 downstream target regions identifies a transcriptional network linking multiple independent coronary artery disease loci . PLoS Genet.11 ( 5 ), e1005202 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• May D , BlowMJ , KaplanTet al. Large-scale discovery of enhancers from human heart tissue . Nat. Genet.44 ( 1 ), 89 – 93 ( 2012 ).
   Web of Science ®Google Scholar
• Shulha HP , CheungI , WhittleCet al. Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons . Arch. Gen. Psychiatry69 ( 3 ), 314 – 324 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Dong X , TsujiJ , LabadorfAet al. The role of H3K4me3 in transcriptional regulation is altered in Huntington’s disease . PLoS ONE10 ( 12 ), e0144398 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Huang Q , WhitingtonT , GaoPet al. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding . Nat. Genet.46 ( 2 ), 126 – 135 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Northcott PA , LeeC , ZichnerTet al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma . Nature511 ( 7510 ), 428 – 434 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Yashiro-Ohtani Y , WangH , ZangCet al. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia . Proc. Natl Acad. Sci. USA111 ( 46 ), e4946 – e4953 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Alekseyenko AA , WalshEM , WangXet al. The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains . Genes Dev.29 ( 14 ), 1507 – 1523 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhang J , Dominguez-SolaD , HusseinSet al. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis . Nat. Med.21 ( 10 ), 1190 – 1198 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Chan KM , FangD , GanHet al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression . Genes Dev.27 ( 9 ), 985 – 990 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Mack SC , WittH , PiroRMet al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy . Nature506 ( 7489 ), 445 – 450 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Akhtar-Zaidi B , Cowper-Sal-LariR , CorradinOet al. Epigenomic enhancer profiling defines a signature of colon cancer . Science336 ( 6082 ), 736 – 739 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mohammed H , RussellIA , StarkRet al. Progesterone receptor modulates ERalpha action in breast cancer . Nature523 ( 7560 ), 313 – 317 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Rondinelli B , RosanoD , AntoniniEet al. Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer . J. Clin. Invest.125 ( 12 ), 4625 – 4637 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ryan RJ , DrierY , WhittonHet al. Detection of enhancer-associated rearrangements reveals mechanisms of oncogene dysregulation in B-cell lymphoma . Cancer Discov.5 ( 10 ), 1058 – 1071 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Rui L , EmreNC , KruhlakMJet al. Cooperative epigenetic modulation by cancer amplicon genes . Cancer Cell18 ( 6 ), 590 – 605 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kim K , PunjV , ChoiJet al. Gene dysregulation by histone variant H2A.Z in bladder cancer . Epigenetics Chromatin6 ( 1 ), 34 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ram O , GorenA , AmitIet al. Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells . Cell147 ( 7 ), 1628 – 1639 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nagarajan RP , ZhangB , BellRJet al. Recurrent epimutations activate gene body promoters in primary glioblastoma . Genome Res.24 ( 5 ), 761 – 774 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Nabilsi NH , DeleyrolleLP , DarstRP , RivaA , ReynoldsBA , KladdeMP . Multiplex mapping of chromatin accessibility and DNA methylation within targeted single molecules identifies epigenetic heterogeneity in neural stem cells and glioblastoma . Genome Res.24 ( 2 ), 329 – 339 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Agirre X , CastellanoG , PascualMet al. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers . Genome Res.25 ( 4 ), 478 – 487 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Schodel J , BardellaC , SciesielskiLKet al. Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression . Nat. Genet.44 ( 4 ), 420 – 425 , S421 – S422 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Oldridge DA , WoodAC , Weichert-LeaheyNet al. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism . Nature528 ( 7582 ), 418 – 421 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ji X , DadonDB , AbrahamBJet al. Chromatin proteomic profiling reveals novel proteins associated with histone-marked genomic regions . Proc. Natl Acad. Sci. USA112 ( 12 ), 3841 – 3846 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sharma NL , MassieCE , Ramos-MontoyaAet al. The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man . Cancer Cell23 ( 1 ), 35 – 47 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Augustyn A , BorromeoM , WangTet al. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers . Proc. Natl Acad. Sci. USA111 ( 41 ), 14788 – 14793 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Herranz D , Ambesi-ImpiombatoA , PalomeroTet al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia . Nat. Med.20 ( 10 ), 1130 – 1137 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Tomazou EM , SheffieldNC , SchmidlCet al. Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1 . Cell Rep.10 ( 7 ), 1082 – 1095 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Tang Z , LuoOJ , LiXet al. CTCF-mediated human 3D genome architecture reveals chromatin topology for transcription . Cell163 ( 7 ), 1611 – 1627 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Tehranchi AK , MyrthilM , MartinT , HieBL , GolanD , FraserHB . Pooled ChIP-seq links variation in transcription factor binding to complex disease risk . Cell165 ( 3 ), 730 – 741 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Vardabasso C , Gaspar-MaiaA , HassonDet al. Histone variant H2A.Z.2 mediates proliferation and drug sensitivity of malignant melanoma . Mol. Cell59 ( 1 ), 75 – 88 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• McCabe MT , OttHM , GanjiGet al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations . Nature492 ( 7427 ), 108 – 112 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Funato K , MajorT , LewisPW , AllisCD , TabarV . Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation . Science346 ( 6216 ), 1529 – 1533 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Seumois G , ChavezL , GerasimovaAet al. Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility . Nat. Immunol.15 ( 8 ), 777 – 788 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Schenk T , ChenWC , GollnerSet al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia . Nat. Med.18 ( 4 ), 605 – 611 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Del Rosario RC , PoschmannJ , RouamSLet al. Sensitive detection of chromatin-altering polymorphisms reveals autoimmune disease mechanisms . Nat. Methods12 ( 5 ), 458 – 464 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Farh KK , MarsonA , ZhuJet al. Genetic and epigenetic fine mapping of causal autoimmune disease variants . Nature518 ( 7539 ), 337 – 343 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Vermunt MW , ReininkP , KorvingJet al. Large-scale identification of coregulated enhancer networks in the adult human brain . Cell Rep.9 ( 2 ), 767 – 779 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Koues OI , KowalewskiRA , ChangLWet al. Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma . Immunity42 ( 1 ), 186 – 198 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Liu F , HonGC , VillaGRet al. EGFR mutation promotes glioblastoma through epigenome and transcription factor network remodeling . Mol. Cell60 ( 2 ), 307 – 318 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Stefan M , WeiC , LombardiAet al. Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity . Proc. Natl Acad. Sci. USA111 ( 34 ), 12562 – 12567 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Xu K , WuZJ , GronerACet al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent . Science338 ( 6113 ), 1465 – 1469 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Benyoucef A , PaliiCG , WangCet al. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia . Genes Dev.30 ( 5 ), 508 – 521 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chapuy B , McKeownMR , LinCYet al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma . Cancer Cell24 ( 6 ), 777 – 790 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Loven J , HokeHA , LinCYet al. Selective inhibition of tumor oncogenes by disruption of super-enhancers . Cell153 ( 2 ), 320 – 334 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Knoechel B , RoderickJE , WilliamsonKEet al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia . Nat. Genet.46 ( 4 ), 364 – 370 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Cotney J , MuhleRA , SandersSJet al. The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment . Nat. Commun.6 , 6404 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sugathan A , BiagioliM , GolzioCet al. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors . Proc. Natl Acad. Sci. USA111 ( 42 ), E4468 – E4477 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Flavahan WA , DrierY , LiauBBet al. Insulator dysfunction and oncogene activation in IDH mutant gliomas . Nature529 ( 7584 ), 110 – 114 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lu T , AronL , ZulloJet al. REST and stress resistance in ageing and Alzheimer’s disease . Nature507 ( 7493 ), 448 – 454 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Chen K , ChenZ , WuDet al. Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes . Nat. Genet.47 ( 10 ), 1149 – 1157 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hock H . A complex Polycomb issue: the two faces of EZH2 in cancer . Genes Dev.26 ( 8 ), 751 – 755 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Arrowsmith CH , BountraC , FishPV , LeeK , SchapiraM . Epigenetic protein families: a new frontier for drug discovery . Nat. Rev. Drug Discov.11 ( 5 ), 384 – 400 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Van Galen P , VinyAD , RamOet al. A multiplexed system for quantitative comparisons of chromatin landscapes . Mol. Cell61 ( 1 ), 170 – 180 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Herz HM , HuD , ShilatifardA . Enhancer malfunction in cancer . Mol. Cell53 ( 6 ), 859 – 866 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gu B , LeeMG . Histone H3 lysine 4 methyltransferases and demethylases in self-renewal and differentiation of stem cells . Cell & Biosci.3 ( 1 ), 39 ( 2013 ).
   PubMedGoogle Scholar
• Lupianez DG , KraftK , HeinrichVet al. Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions . Cell161 ( 5 ), 1012 – 1025 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Savic D , PartridgeEC , NewberryKMet al. CETCh-seq: CRISPR epitope tagging ChIP-seq of DNA-binding proteins . Genome Res.25 ( 10 ), 1581 – 1589 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bonhoure N , BounovaG , BernasconiDet al. Quantifying ChIP-seq data: a spiking method providing an internal reference for sample-to-sample normalization . Genome Res.24 ( 7 ), 1157 – 1168 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Orlando David A , Chen MeiW , Brown VictoriaEet al. Quantitative ChIP-seq normalization reveals global modulation of the epigenome . Cell Rep.9 ( 3 ), 1163 – 1170 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Grzybowski AT , ChenZ , RuthenburgAJ . Calibrating ChIP-seq with nucleosomal internal standards to measure histone modification density genome wide . Mol. Cell58 ( 5 ), 886 – 899 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Adli M , BernsteinBE . Whole-genome chromatin profiling from limited numbers of cells using nano-ChIP-seq . Nat. Protoc.6 ( 10 ), 1656 – 1668 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Shankaranarayanan P , Mendoza-ParraMA , Van GoolW , TrindadeLM , GronemeyerH . Single-tube linear DNA amplification for genome-wide studies using a few thousand cells . Nat. Protoc.7 ( 2 ), 328 – 338 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zwart W , KoornstraR , WesselingJ , RutgersE , LinnS , CarrollJS . A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples . BMC Genomics14 , 232 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lara-Astiaso D , WeinerA , Lorenzo-VivasEet al. Immunogenetics. Chromatin state dynamics during blood formation . Science345 ( 6199 ), 943 – 949 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Valensisi C , LiaoJL , AndrusC , BattleSL , HawkinsRD . cChIP-seq: a robust small-scale method for investigation of histone modifications . BMC Genomics16 ( 1 ), 1083 ( 2015 ).
   PubMedGoogle Scholar
• Schmidl C , RendeiroAF , SheffieldNC , BockC . ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors . Nat. Methods12 ( 10 ), 963 – 965 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Rotem A , RamO , ShoreshNet al. Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state . Nat. Biotechnol.33 ( 11 ), 1165 – 1172 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Cao Z , ChenC , HeB , TanK , LuC . A microfluidic device for epigenomic profiling using 100 cells . Nat. Methods12 ( 10 ), 959 – 962 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Brind’Amour J , LiuS , HudsonM , ChenC , KarimiMM , LorinczMC . An ultra-low-input native ChIP-seq protocol for genome-wide profiling of rare cell populations . Nat. Commun.6 , 6033 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Egelhofer TA , MinodaA , KlugmanSet al. An assessment of histone-modification antibody quality . Nat. Struct. Mol. Biol.18 ( 1 ), 91 – 93 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Rothbart SB , DicksonBM , RaabJRet al. An interactive database for the assessment of histone antibody specificity . Mol. Cell59 ( 3 ), 502 – 511 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Chen Y , NegreN , LiQet al. Systematic evaluation of factors influencing ChIP-seq fidelity . Nat. Methods9 ( 6 ), 609 – 614 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y , LiuT , MeyerCAet al. Model-based analysis of ChIP-Seq (MACS) . Genome Biol.9 ( 9 ), R137 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• IHEC . Reference epigenome standards . http://ihec-epigenomes.org/research/reference-epigenome-standards/
   Google Scholar
• Yao L , BermanBP , FarnhamPJ . Demystifying the secret mission of enhancers: linking distal regulatory elements to target genes . Crit. Rev. Biochem. Mol. Biol.50 ( 6 ), 550 – 573 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Yan H , TianS , SlagerSL , SunZ , OrdogT . Genome-wide epigenetic studies in human disease: a primer on -omic technologies . Am. J. Epidemiol.183 ( 2 ), 96 – 109 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Ross-Innes CS , StarkR , TeschendorffAEet al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer . Nature481 ( 7381 ), 389 – 393 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Katainen R , DaveK , PitkanenEet al. CTCF/cohesin-binding sites are frequently mutated in cancer . Nat. Genet.47 ( 7 ), 818 – 821 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Robinson JT , ThorvaldsdottirH , WincklerWet al. Integrative genomics viewer . Nat. Biotechnol.29 ( 1 ), 24 – 26 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• University of California Santa Cruz . UCSC genome browser . https://genome.ucsc.edu/
   Google Scholar
• Zhou X , WangT . Using the Wash U Epigenome Browser to examine genome-wide sequencing data . Curr. Protoc. Bioinform.10 ( Unit10 ), 10 ( 2012 ).
   Google Scholar
• MIT Computational Biology Group . Epilogos . http://epilogos.broadinstitute.org/
   Google Scholar
• Ernst J , KellisM . ChromHMM: automating chromatin-state discovery and characterization . Nat. Methods09 ( 3 ), 215 – 216 ( 2012 ).
   Google Scholar
• Marx V . Visualizing epigenomic data . Nat. Methods12 ( 06 ), 499 – 502 ( 2015 ).
   PubMedGoogle Scholar
• Korkmaz G , LopesR , UgaldeAPet al. Functional genetic screens for enhancer elements in the human genome using CRISPR–Cas9 . Nat. Biotechnol.34 ( 02 ), 192 – 198 ( 2016 ).
   PubMedGoogle Scholar